Clinical Trial Update: Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism [Phase 4]

View source ↗

Summary

Phase 4 trial of paliperidone palmitate for bipolar disorder complicated by alcoholism has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• INVEGA SUSTENNA (PALIPERIDONE PALMITATE)

Snippet

Sponsor: University of Miami | Conditions: Bipolar Disorder | Phase 4 | Status: WITHDRAWN